MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Functional Rating Scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington’s disease: The importance of the patient voice in scale development

    R. Fuller, P. Feigenbaum, N. Lapelle, S. Sathe, C. Fitzer-Attas, M. Guttman, C. Goetz, S. Luo, B. Tilley, P. Dalal, C. Sampaio, G. Stebbins (Princeton, USA)

    Objective: Use focus groups, a Delphi panel, and multiple iterations of cognitive pretesting to develop a patient-reported outcome (PRO) measure of function in Huntington’s disease…
  • 2022 International Congress

    Clinical,imaging and genetic correlations in a Neuronal Brain Iron accumulation cohort from India

    K P. Divya, A. Cherian, M. Chandarana, S. Krishnan (Thiruvananthapuram, India)

    Objective: To correlate, clinical and magnetic resonance imaging (MRI) characteristics, of patients with neurodegeneration with brain iron accumula­tion (NBIA), with genetics and establish genotype-phenotype correlations…
  • 2022 International Congress

    Impact of foslevodopa/foscarbidopa on key clinical and patient-reported outcomes in patients with aPD: Responder analysis of two Phase 3 clinical trials

    M. Soileau, J. Aldred, A. Antonini, C. Carroll, V. Fung, T. Henriksen, R. Pahwa, D. Santos Garcia, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, A. Spiegel, M. Facheris, J. Zamudio, P. Kukreja, KR. Chaudhuri (Georgetown, USA)

    Objective: To evaluate the effect of foslevodopa/foscarbidopa (LDP/CDP, ABBV-951) on clinical and patient-reported outcomes in advanced Parkinson’s disease (aPD) patients using minimal clinically important difference…
  • 2022 International Congress

    MOTOR DISORDERS IN CONGENITAL SPINAL PATHOLOGY IN CHILDREN

    F. Doniyorova (Tashkent, Uzbekistan)

    Objective: The aim of the work was to assess movement disorders, to determine the nature of locomotor status disorders in children with various deformities of…
  • 2022 International Congress

    Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

    C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)

    Objective: We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson’s disease (PD), defined as individuals providing regular…
  • 2022 International Congress

    Swimming against the current: Successful implementation of functional neurosurgery programs in underserved regions of Chile

    M. Contreras Pinto, J. Hortal, G. Fernandez (la serena, Chile)

    Objective: To show the experience of implementing a functional neurosurgery program with Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD), in low-income regions…
  • 2022 International Congress

    WHODAS 2.0 to access functional disabilities of Wilson disease’s patients

    P. Ribeiro, E. Silva, F. Nery, H. Miranda, I. Pedroto, J. Ferreira, J. Gandara, L. Maia, P. Fernandes, S. Ferreira, M. Magalhães (Matosinhos, Portugal)

    Objective: We aim to analyze the disability status of WD patients by using the World Health Organization Disability Assessment Schedule 2.0 scale (WHODAS 2.0) and…
  • 2022 International Congress

    Combined anti N-Methyl-D- Aspartate receptor (NMDAR) encephalitis with autoimmune thyroiditis (AT), with good clinical recovery.

    M. Farghal, M. Abu Hashish (Ahmadi, Kuwait)

    Objective: To report anti NMDAR encephalitis patient, with evidence of AT, and to explain her clinical presentation, management and outcome. Background: Autoimmune encephalitis(AE) is nowadays…
  • 2022 International Congress

    Specificity of neuronal activity in globus pallidus in patients with DYT1 dystonia

    I. Dzhalagoniya, S. Usova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: The aim of this study was a comparative analysis of the neuronal activity of globus pallidus in patients with DYT1 dystonia and idiopathic dystonia.…
  • 2022 International Congress

    Fear of progression is predicted by anxiety and self-efficacy but not disease-specific parameters in patients with Parkinson’s disease: data from a multicenter cross-sectional study

    AK. Folkerts, L. Haarmann, J. Nielsen, J. Saliger, M. Eschweiler, H. Karbe, N. Allert, V. Vida, C. Trenkwalder, A. Kruse, H. Oelsner, G. Ebersbach, E. Kalbe (Cologne, Germany)

    Objective: To examine Fear of progression (FoP) prevalence and to analyze FoP predictors in a large Parkinson’s disease (PD) sample. Background: FoP is a reactive…
  • « Previous Page
  • 1
  • …
  • 672
  • 673
  • 674
  • 675
  • 676
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley